1588P SARS-CoV-2 antibody seroprevalence and safety of vaccines in cancer patients who recovered from COVID-19

Detalles Bibliográficos
Autores principales: Patel, M., Felip, E., Sharkey, R., Krengli, M., Chester, J.D., Sita-Lumsden, A., Mukherjee, U., Russell, B., Loizidou, A., Colomba, J., Cruz, C. Andrea, Cabirta, A., Camps, I. Ruiz, Brunet, J., Sureda, A., Patriarca, A., Tondini, C., Pinato, D.J., Cortellini, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society for Medical Oncology. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454348/
http://dx.doi.org/10.1016/j.annonc.2021.08.1581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454348/
http://dx.doi.org/10.1016/j.annonc.2021.08.1581

Ejemplares similares